NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates
This article was originally published in The Gray Sheet
Executive Summary
A new upgrade to the National Institutes of Health’s1995 regulations overseeing researcher conflict of interests is intended as “an insurance plan” against potential trouble downstream, NIH Director Francis Collins says. But a key change in the final rule compared to an earlier proposal is attracting criticism from transparency advocates.